Medicare Enrolled

Dr. Chad Hendrickson, M.D.

Dermatology · Slippery Rock, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
100 INNOVATION DR, Slippery Rock, PA 16057
7247947923
In practice since 2005 (20 years)
NPI: 1780665075 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hendrickson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hendrickson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hendrickson

Dr. Chad Hendrickson is a dermatology specialist in Slippery Rock, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hendrickson performed 2,744 Medicare services across 1,940 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hendrickson received a total of $2,485 from 17 pharmaceutical and/or device companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hendrickson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in PA $2,485 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,744
Medicare services
Top 34% in PA for dermatology
1,940
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~137 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
806 $5 $42
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
651 $57 $118
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
372 $35 $102
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
208 $74 $174
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
140 $62 $156
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $35 $71
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
89 $65 $169
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $89 $171
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
36 $109 $277
Destruction of cancerous skin growth on face, 1.1-2.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter.
34 $128 $323
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
32 $38 $83
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm 31 $225 $480
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
30 $42 $119
Surgical removal of facial skin cancer, 1.1-2.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters.
28 $105 $426
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
23 $2 $5
Chemotherapy administration, 1-7 injections
This procedure involves the administration of chemotherapy medication through one to seven separate injections.
21 $56 $133
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
19 $189 $474
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $120 $260
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 15 $121 $295
Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm
Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters.
11 $120 $503
Ear tissue biopsy
A procedure to remove a small sample of tissue from the ear for laboratory examination.
11 $63 $176
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,485
Total received (2020-2024)
Avg $497/year across 5 years
Top 43% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,283 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202 (8.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,700
2023
$571
2022
$101
2021
$13
2020
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$469
Novartis Pharmaceuticals Corporation
$232
LEO Pharma Inc.
$209
Janssen Biotech, Inc.
$155
GENZYME CORPORATION
$139
Regeneron Healthcare Solutions, Inc.
$92
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
Organogenesis Inc.
$54
Incyte Corporation
$50
UCB, Inc.
$44
Dermavant Sciences, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Arcutis Biotherapeutics, Inc.
$38
PFIZER INC.
$38
Ortho Dermatologics, a division of Bausch Health US, LLC
$24
Lilly USA, LLC
$14
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2020-2024) ›
ABBVIE INC.
$648
Novartis Pharmaceuticals Corporation
$435
Janssen Biotech, Inc.
$329
LEO Pharma Inc.
$209
GENZYME CORPORATION
$165
Regeneron Healthcare Solutions, Inc.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
Dermavant Sciences, Inc.
$84
Lilly USA, LLC
$78
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
Arcutis Biotherapeutics, Inc.
$58
Organogenesis Inc.
$54
PFIZER INC.
$51
Incyte Corporation
$50
UCB, Inc.
$44
Ortho Dermatologics, a division of Bausch Health US, LLC
$24
Amgen Inc.
$16
Top 3 companies account for 56.8% of all-time payments
Associated products mentioned in payments ›
ADBRY · Bimzelx · COSENTYX · CYLTEZO · Cabtreo · DUPIXENT · EUCRISA · ILUMYA · OPZELURA · Otezla · PURAPLY AM · RINVOQ · SKYRIZI · SPEVIGO · TALTZ · TREMFYA · VTAMA · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Slippery Rock?
Compare dermatologists in the Slippery Rock area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
7
Per 100K population
3.6
County median income
$86,775
Nearest hospital
GROVE CITY MEDICAL CENTER
9.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hendrickson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hendrickson experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Hendrickson performed 806 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hendrickson receive payments from pharmaceutical companies?
Yes. Dr. Hendrickson received a total of $2,485 from 17 companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hendrickson's costs compare to other dermatologists in Slippery Rock?
Dr. Hendrickson's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hendrickson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →